Key Figures Q2 2020

SEK m,

unless otherwise stated

2020

Apr-Jun

2019

Apr-Jun

2020

Jan-Jun

2019

Jan-Jun

2019

Jan-Dec

2019-2020

Apr-Jun Δ

Net revenues

179.1

201.2

354.2

375.5

844.8

-11%

Cost of goods sold

-19.9

-31.3

-39.9

-56.6

-105.6

-36%

Operating expenses

-172.5

-117.1

-293.6

-265.1

-508.0

47%

EBIT

-13.3

52.8

20.7

53.8

231.2

-125%

EBITmargin, %

-7.4

26.2

5.8

14.3

27.4

-33.7 ppt

EBITDA

-9.0

60.4

30.1

72.3

272.1

-115%

Earnings per share, before dilution, SEK

-0.94

1.54

1.44

1.93

6.33

-161%

Earnings per share, after dilution, SEK

-0.94

1.51

1.44

1.90

6.20

-162%

Cash flow from operating activities

-7.2

46.1

40.9

97.1

287.0

-116%

Cash and cash equivalents

677.2

697.0

677.2

679.0

816.8

-3%


Net revenues and EBIT per segment Q2 2020

SEK m

Net Revenues

EBIT

 

2020

Apr-Jun

2019

Apr-Jun

2020

Jan-Jun

2019

Jan-Jun

2019

Jan-Dec

2020

Apr-Jun

2019

Apr-Jun

2020

Jan-Jun

2019

Jan-Jun

 2019

Jan-Dec

ZUBSOLV® US

172.5

184.4

336.4

346.1

719.2

-

-

-

-

-

US Pharma – total

172.5

184.4

336.4

346.1

719.2

88.8

83.8

164.5

152.0

347.1

Digitala Therapeutics

-

-

-

-

-

-35.5

-

-47.6

-

-0.9

Digitala Therapeutics – total

-

-

-

-

-

-35.5

-

-47.6

-

-0.9

Abstral® royalties

3.5

13.1

12.2

24.0

112.6

-

-

-

-

-

Edluar® royalties

3.1

2.4

5.5

4.2

11.6

-

-

-

-

-

ZUBSOLV® - ex US

-

-

0.1

-

0.1

-

-

-

-

-

OX-MPI

-

1.3

-

1.3

1.4

-

-

-

-

-

HQ & Pipeline – total

6.6

16.8

17.8

29.4

125.6

-66.6

-31.0

-96.2

-98.1

-115,0

Total

179.1

201.2

354.2

375.5

844.8

-13.3

52.8

20.7

53.8

231,2

Cash flow Q2 2020

 

SEK m

2020

Apr-Jun

2019

Apr-Jun

2020

Jan-Jun

2019

Jan-Jun

2019

Jan-Dec

Cash flow from operating activities

-7.2

46.1

40.9

97.1

287.0

Investment activities

-106.0

-0.8

-109.9

-0.8

-22.4

Financing activities

-33.9

-3.8

-102.7

-14.5

-53.7

Cash flow (excl exchange rate differences)

-147.1

41.6

-171.7

81.7

210.8

Liquid funds

677.2

697.0

677.2

697.0

816.8